Related Experiment Video
Updated: Nov 30, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.8K
Current delivery limitations of proton PBS for FLASH
Wei Zou1, Eric S Diffenderfer1, Keith A Cengel1
1Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA.
Summary
Achieving FLASH dose rates with proton pencil beam scanning (PBS) is challenging for large fields due to slew and switching times. However, local FLASH delivery is possible, guiding future proton radiotherapy adaptation.
Area of Science:
- Medical Physics
- Radiation Oncology
- Particle Therapy
Background:
- FLASH radiotherapy offers potential normal tissue sparing.
- Proton Pencil Beam Scanning (PBS) is a promising technique for delivering FLASH doses.
- PBS mechanics may limit effective dose rates.
Purpose of the Study:
- To investigate the effective dose rate achievable with PBS under various conditions.
- To extrapolate PBS dose rates at high cyclotron beam currents.
- To identify limitations and possibilities for FLASH dose delivery using PBS.
Main Methods:
- Measurements from clinical and research beams (uniform single energy and spread-out Bragg Peak PBS fields).
- Extrapolation of PBS dose rates to high cyclotron currents (350, 500, 800 nA).
- Analysis of factors influencing effective field dose rate: cyclotron current, spot spacing, slew time, and field size.
Main Results:
- FLASH dose rates (≥40 Gy/s) are achievable for small fields (<4x4 cm²) with >500 nA cyclotron current if slew and switching times are ignored.
- Slew time and energy switching time are critical limiting factors for high effective dose rates.
- Dose rate-time structures were analyzed, and the proportion of dose delivered at FLASH rates was studied.
Conclusions:
- Achieving full FLASH dose rates in large fields or volumes with PBS is difficult.
- Local FLASH delivery, where a portion of the total dose is delivered at FLASH rates, is feasible.
- Findings can guide the adaptation of current clinical proton PBS for FLASH proton radiotherapy, pending further understanding of FLASH radiobiology.

